How aging affects cervical cancer outcomes in women with HIV in Zambia
The Impact of Biologic Aging on Immunity-Related Cervical Cancer Outcome Disparities Among Women Living with HIV in Zambia
This study is looking at how aging affects cervical cancer treatment in women with HIV in Zambia, aiming to find ways to improve care and support for those who may not have easy access to screening and treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10931755 on NIH RePORTER |
What this research studies
This research investigates the relationship between biological aging and cervical cancer outcomes among women living with HIV in Zambia. It focuses on how premature aging, often seen in individuals with HIV, may influence the effectiveness of standard treatments like chemoradiation therapy. By examining the epigenetic changes associated with aging, the study aims to understand disparities in cancer progression and treatment responses in this vulnerable population. The research seeks to improve access to cervical cancer screening and treatment for women in underserved communities.
Who could benefit from this research
Good fit: Ideal candidates for this research are women living with HIV in Zambia, particularly those who are at risk for cervical cancer.
Not a fit: Patients who do not live in Zambia or who do not have HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies and outcomes for women living with HIV who are at risk for cervical cancer.
How similar studies have performed: Previous research has shown that understanding biological aging can impact treatment outcomes in cancer, suggesting this approach may yield valuable insights.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Lin, Lilie Leming — University of Tx Md Anderson Can Ctr
- Study coordinator: Lin, Lilie Leming
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.